|
William Fletcher is the Chairman of Teva North America. Prior to that he was the President & CEO of Teva’s North American activities from 1985 until the end of 2004. Teva, one of Israel’s largest industrial companies, holds the leading position in the global generic drug industry and commands a significant presence in the specialty neurology market. Mr. Fletcher served as Vice President, Sales and Marketing of the Pennsylvania based Lemmon Company (1980 to 1983) and then as President (1983-1985) following the company’s acquisition by Teva and WR Grace. Prior to 1980, Mr. Fletcher was Business Development Manager and International Marketing Manager of Synthelabo, a pharmaceutical subsidiary of L’Oreal in Paris. From 1970 to 1977 he served in various international sales and marketing positions for Hoffman-LaRoche. Mr. Fletcher graduated in International Marketing from Woolwich Polytechnic, London (now Greenwich University) in 1969. He serves as a Board Member for several Teva subsidiary companies in North America and Europe, and is a Director of Sportwall International Inc., a growth company in the interactive fitness industry. | 